Page 6 - Commercial Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Transformative, leading allogeneic NKT cell platform technology expands Athenex's cell therapy development capability Platform has broad applications based on transducing NKT cells with chimeric antigen receptors (CARs) and T cell receptors (TCRs) to target hematological and solid cancers, respectively Total potential consideration of $185 million, comprising $70 million upfront primarily in Athenex common stock, and $115 million in development milestones Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of...

05/05/2021 | Press release | Distributed by Public on 05/05/2021 00:16 Kuur Therapeutics Ltd - Athenex to Acquire Kuur Therapeutics to expand cell therapy development with off-the-shelf engineered CAR-NKT platform Transformative, leading allogeneic NKT cell platform technology expands Athenex's cell therapy development capability Platform has broad applications based on transducing NKT cells with chimeric antigen receptors (CARs) and T cell receptors (TCRs) to target hematological and solid cancers, respectively Total potential consideration of $185 million, comprising $70 million upfront pri...

Share this article Share this article NEW YORK, April 26, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) and certain of its officers.  The class action, filed in the United States District Court for the Western District of New York, and docketed under 21-cv-00413, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquire Athenex common stock between August 7, 2019 and February 26, 2021, inclusive (the "Class Period").  This...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Athenex, Inc., of Class Action Lawsuit and Upcoming Deadline – ATNX 04/24/2021 | 01:15am EDT Send by mail : Message : Required fields NEW YORK, April 24, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) and certain of its officers.   The class action, filed in the United States District Court for the Western District of New York, and docketed under 21-cv-00413, is on behalf of a ...

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) and...